Vertaling van "current standard " (Nederlands → Frans) :

The evaluation is based on current standards and guidelines on the quality, safety and clinical efficacy of medicines and health products.
The evaluation is based on current standards and guidelines on the quality, safety and clinical efficacy of medicines and health products.

The Production & Distribution department of the FAMHP is responsible firstly for overseeing the conformity to current standards, guidelines and legal requirements for the manufacture, distribution and dispensing of medicines and health products and secondly for granting authorisations, recognitions and certificates, as well as for combating illegal practices and monitoring pharmacies.
The Production & Distribution department of the FAMHP is responsible firstly for overseeing the conformity to current standards, guidelines and legal requirements for the manufacture, distribution and dispensing of medicines and health products and secondly for granting authorisations, recognitions and certificates, as well as for combating illegal practices and monitoring pharmacies.

The drug has been shown previously to significantly reduce the relapse rate compared to intra-muscular interferon beta 1a, the current standard of care, and also to delay disability progression versus placebo.
Ce médicament a démontré sa capacité de réduire considérablement le taux de rechute comparé à l’interféron bêta 1a en injection intramusculaire, la norme actuelle de soin, et aussi de retarder la progression de l’invalidité par rapport à un placebo.

EPO906 (ovarian cancer) was discontinued after a pivotal trial failed to achieve its primary end point in the form of improved overall survival over current standard of care (liposomal doxorubicin).
EPO906 (cancer des ovaires) a été arrêté après qu’un essai pivot a échoué à répondre à son critère principal d’efficacité sous la forme d’une amélioration globale du taux de survie par rapport au standard de soins courant (doxorubicine liposomale).

Lijst van de gebruikte afkortingen cGTP Current Good Tissue Practice EG Europese Gemeenschap EN Europese normen EU GMP European Union’s good manufacturing practice FDA Food and Drug Administration FMEA Failure Mode and Effects Analysis HACCP Hazard Analysis and Critical Control Points HEPA High-efficiency particulate air HGR Hoge Gezondheidsraad HVAC Heating, ventilation, and air conditioning ICSI Intra cytoplasmatische sperma injectie ISO International Organization for Standardization KB Koninklijk besluit KVE Kolonievormende eenheden MLM Menselijk lichaamsmateriaal NBN Nationale Belgische normen TSA Tryptic Soy Agar ULPA Ultra-low particulate air USP United States Pharmacopeia VS Verenigde Staten WHO World Health Organisation
Liste des abréviations utilisées AR Arrêté royal CE Communauté européenne cGTP Current Good Tissue Practice CSS Conseil Supérieur de la Santé EN European norms EU GMP European Union's good manufacturing practice FDA Food and Drug Administration FMEA Failure Mode and Effects Analysis HACCP Hazard Analysis and Critical Control Points HEPA High-efficiency particulate air HVAC Heating, ventilation, and air conditioning ICSI Injection intracytoplasmique de sperme ISO International Organization for Standardization MCH Matériel corporel humain NBN Bureau de Normalisation OMS Organisation mondiale de la santé TSA Tryptic Soy Agar UFC Unité formant colonie ULPA Ultra-low particulate air US United States USP United States Pharmacopeia

Consistent with this focused research strategy, new Phase II data demonstrates that ACZ885, currently marketed as Ilaris for the rare disease cryopyrin-associated periodic syndrome (CAPS), provided highly statistically significant risk reduction of acute flares in gout patients compared to the anti-inflammatory standard of care.
Cette approche stratégique est illustrée par ACZ885, un médicament actuellement commercialisé sous la marque Ilaris pour traiter le syndrome périodique associé à la cryopirine (CAPS), une maladie rare. De nouveaux résultats d’une étude de phase II ont montré que ce médicament induisait une réduction importante, hautement significative sur le plan statistique, du risque de crises aiguës de goutte par comparaison avec le traitement anti-inflammatoire standard.